FMCG giant Nestle India said on Friday that as inflationary pressures have begun to ease, pricing may need to be revised lower. Nestle India also predicted double-digit volume growth for this year.
More than 20% of sales are anticipated to come from rural regions, where Nestle India is growing its retail network. Additionally, it is growing its line of “Nestle Health Science” products for the pharmacy.
According to Nestle India Chairman & Managing Director Suresh Narayanan, “Unless there is an adversity because of the El Nino effect, which is being talked about in relation to the monsoons, I would expect the demand position will be fairly stable for us going forward and we should be able to continue on the path of double-digit growth.”
Twenty of the previous 25 quarters have had volume increase recorded by the corporation.
“I believe that inflationary pressures are beginning to ease. Therefore, I do hope that the pricing pressures will begin to ease,” he said.
“We are once again seeing volume increase. Five percent increase in the first quarter… In the future, he said, “I believe we will be able to return to the regime of a more balanced growth between the value and volume if there is a decrease in the inflationary pressures.
He claims that throughout the previous 6-7 years, the company’s CAGR (Compound Annual Growth Rate) was between 10% and 11%.
“Of this, price has made up around 2 to 3 percent, while volume has made up about 7 to 8 percent. It decreased in volume last year. “The balance was price growth; the volume growth was lower at about 4%,” he added.
According to Narayanan, “we will look at appropriate measures” in response to the question of whether Nestle will pass on the benefits of reduced inflationary pressures.
“At this time, we have not reached a point where the relief from inflationary pressures allows us to relax our standards for pricing.
But moving ahead, he said, “we will examine and make modifications to the mix and to the pricing if there are substantial gains that we perceive coming out of the procurement costs of raw materials, most definitely in terms of value delivery.
Additionally, he declared that milk prices are “on fire” and made some inferences about potential actions involving its milk-based portfolio.
We are keeping an eye on the situation to see how things develop in the next months. There won’t be any pricing adjustments until they are absolutely essential since the price rises are rather pronounced and there is also a supply problem, he said.
In the next 12 to 18 months, Nestle plans to touch 1.2 lakh villages with a population greater than 2,000 as part of its expansion into the rural market.
Currently, 20% of Nestle India’s sales come from rural areas, and the company expects this percentage to increase by about 25%. Nestle India is present in 90,000 villages.
In rural marketplaces, the smaller packets are undoubtedly gaining ground. In actuality, there is up-trading going on.
He said that companies like KitKat and Nescafe are also beginning to get momentum. “For example, in our Maggi Noodles, some of our multi packs, the sales proportion in rural markets, is starting to go up,” he said. Also gaining appeal are nutrition products.
He noted that rural customers now want better brands, more reliable brands, and companies that are more quality-focused.
Narayanan said that Nestle India is “quite optimistic” about the pet care and health science portfolio business.
“We are working with a name in health research that is world-class. He stated that there are plans for more releases.
Additionally, Nestle offers items in the therapeutic and diabetes markets.
“We are also considering additional supplements we may release. That’s good news considering the nation also faces a variety of health-related issues. And as a business, we are well-versed in this area,” Narayanan added.
Nestle India’s milk and nutrition division already has a significant presence in the pharmacy channels.
We are rather well-represented in both traditional pharmacies and the growing e-pharmacy… The 11 goods in the health science portfolio are distributed via chemist channels and are mostly suggested by hospitals or doctors. So, in the pharmacy channels, this is what we are utilising and playing to our strengths, he said.
Quick e-commerce will be a major development driver in the e-commerce industry, which now accounts for 7% of Nestle India’s revenue.
“We will keep e-commerce as a strong channel. Having said that, the organised general trade will continue to account for the bulk of the industry, or more than 80% of our industry, he added.
Nestle India, a division of the large Swiss FMCG company Nestle, brought in Rs 16,896.96 crore in sales in 2022.